Impact of Medically Tailored Groceries on Glycemic Control in Medicaid-Insured Adults with Type 2 Diabetes: Insights from a Randomized Controlled Trial

MedXY Editorial Team•Jul 21, 2026•Cardiology

Medically tailored groceries (MTG) significantly reduced HbA1c by 0.40 percentage points compared to usual care in Medicaid-insured adults with type 2 diabetes over 6 months.
Food and nutrition security improved substantially with MTG, doubling and tripling the odds of security respectively.
No significant changes were observed in hypertension or BMI, indicating glucose control benefits without weight or blood pressure alterations.
Both lower-dose and higher-dose grocery interventions yielded comparable benefits, suggesting cost-effective delivery models are feasible.
Results were robust across multiple demographic and clinical subgroups, highlighting broad applicability.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Medically tailored groceries (MTG) significantly reduced HbA1c by 0.40 percentage points compared to usual care in Medicaid-insured adults with type 2 diabetes over 6 months.
Food and nutrition security improved substantially with MTG, doubling and tripling the odds of security respectively.
No significant changes were observed in hypertension or BMI, indicating glucose control benefits without weight or blood pressure alterations.
Both lower-dose and higher-dose grocery interventions yielded comparable benefits, suggesting cost-effective delivery models are feasible.
Results were robust across multiple demographic and clinical subgroups, highlighting broad applicability.